BioNote, Inc. (KRX:377740)
4,760.00
-5.00 (-0.10%)
At close: Sep 11, 2026
| Market Cap | 480.35B -21.8% |
| Revenue (ttm) | 126.41B +12.8% |
| Net Income | -125.69B |
| EPS | -1,246.93 |
| Shares Out | 100.91M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 228.00 (4.79%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 14,799 |
| Open | 4,750.00 |
| Previous Close | 4,765.00 |
| Day's Range | 4,710.00 - 4,780.00 |
| 52-Week Range | 4,050.00 - 6,300.00 |
| Beta | 0.63 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |